首页|慢性HBV感染者外周血可诱导共刺激分子在CD8+T淋巴细胞的表达及其临床意义

慢性HBV感染者外周血可诱导共刺激分子在CD8+T淋巴细胞的表达及其临床意义

扫码查看
目的 探讨慢性乙型肝炎病毒(HBV)感染者外周血可诱导共刺激分子(ICOS)在CD8 + T淋巴细胞的表达特点及临床意义.方法 选取2017 年5 月—2018 年10 月就诊的慢性乙型肝炎(CHB)100 例、HBV-肝硬化(LC)25 例和HBV-慢加急(或亚急)性肝衰竭(ACLF)26 例分别纳入CHB组、HBV-LC组和HBV-ACLF组,健康对照(NC)组35 例来自同期门诊体检健康者.采用流式细胞仪检测各组ICOS在CD8 + T淋巴细胞的表达情况;分析CD8 + T淋巴细胞ICOS表达水平与慢性HBV感染者疾病严重程度、HBV-ACLF预后及并发症的相关性;动态观察HBV-ACLF患者治疗过程中CD8 + T淋巴细胞ICOS表达变化.结果 HBV-ACLF组外周血CD8 + T淋巴细胞ICOS表达比率及平均荧光强度(MFI)均高于CHB组、HBV-LC组和NC组(P<0.05).慢性HBV感染者ICOS的MFI与白蛋白、胆碱酯酶、总胆固醇、血红蛋白呈负相关(r =-0.263、-0.269、-0.273、-0.302,P =0.003、0.003、0.011、0.004);与直接胆红素、天冬氨酸转氨酶、凝血酶原时间、国际标准化比值呈正相关(r =0.248、0.208、0.331、0.315,P =0.005、0.020、0.003、0.009);与HBV-DNA、腹水及感染无明显相关性(P>0.05).治疗过程中,HBV-ACLF患者ICOS的MFI无明显改变.但生存组ICOS的MFI在治疗第1 周时较治疗前上升(P<0.05).结论 HBV-ACLF患者外周血CD8 + T淋巴细胞ICOS的表达水平明显升高,并与肝脏合成功能、炎症程度及预后相关,治疗早期ICOS水平变化有助于预测慢性HBV感染者的预后.
Expression of ICOS in CD8+T Lymphocytes in Peripheral Blood of Pa-tients with Chronic HBV Infection and Its Clinical Significance
Objective To investigate the expression characteristics and clinical significance of inducible costimulatory molecule(ICOS)in CD8 + T lymphocytes in peripheral blood of patients with chronic hepatitis B virus(HBV).Methods From May 2017 to October 2018,100 patients with chronic hepatitis B(CHB),25 patients with HBV-liver cirrhosis(LC)and 26 patients with HBV-acute-on-chronic(or subacute)liver failure(ACLF)were selected and included in the CHB group,HBV-LC group and HBV-ACLF group,respectively.In the healthy control(NC)group,35 people were healthy phys-ical examinees during the same period.The expression of ICOS in CD8 + T lymphocytes was detected by flow cytometry.The correlation between ICOS expression level of CD8 + T lymphocytes and disease severity,prognosis and complications in pa-tients with chronic HBV infection was analyzed.Changes in ICOS expression of CD8 + T lymphocytes in HBV-ACLF patients was dynamically observed during treatment.Results The ICOS expression ratio and mean fluorescence intensity(MFI)of CD8 + T lymphocytes in peripheral blood of HBV-ACLF patients were higher than those in CHB,HBV-LC and NC groups(P<0.05).The MFI of ICOS in CD8 + T lymphocytes of patients with chronic HBV infection was negatively correlated with albumin,cholinesterase,total cholesterol and hemoglobin(r =-0.263,-0.269,-0.273,-0.302,P =0.003,0.003,0.011,0.004),and positively correlated with direct bilirubin,aspartate aminotransferase,prothrombin time and international standardized ratio(r =0.248,0.208,0.331,0.315,P =0.005,0.020,0.003,0.009);however,it had no significant correlation with HBV-DNA,ascites and infection(P>0.05).During treatment,the MFI of ICOS in CD8 + T lymphocyte of HBV-ACLF patients did not change significantly.However,the MFI of ICOS in CD8 + T lymphocyte in survival group was higher at the first week of treatment than that before treatment(P<0.05).Conclusion ICOS expression level of CD8 + T lymphocytes in peripheral blood of HBV-ACLF patients is significantly increased,and is related to liver synthesis function,in-flammation degree and prognosis.Changes in ICOS level in early treatment can help predict the prognosis of patients with chro-nic HBV infection.

Hepatitis B virusHepatitis B,chronicLiver failureLiver cirrhosisInducible costimulatory mole-culeCD8 + T cellAscitesPrognosis

陈春林、张华堂、苏密龙、郑怡娟、苏智军、余雪平、任岚

展开 >

362200 福建晋江,晋江市医院上海市第六人民医院福建医院感染科

362000 福建泉州,福建医科大学附属泉州第一医院感染科

362000 福建泉州,福建医科大学附属泉州第一医院检验科

乙型肝炎病毒 乙型肝炎,慢性 肝衰竭 肝硬化 可诱导共刺激因子 CD8 + T淋巴细胞 腹水 预后

国家自然科学基金资助项目福建省自然科学基金资助项目

823706042023J01239

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(2)
  • 2